Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: Correlation with chemotherapy intensity and clinical outcome

Leukemia Research

Volumn 20, Issue 5, 1996, Pages 441-443

  Lanza, Carlo ^a,b   Gottardi, Enrico ^a   Gaidano, Gianluca ^a   Vivenza, Claudia ^b   Parziale, Adele ^a   Perfetto, Fatima ^a   Fornaci, Marinella ^a   Barisone, Elena ^b   Madon, Enrico ^b   Basso, Giuseppe ^b   Saglio, Giuseppe ^a,c  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CNR   (Italy)

Author keywords

ALL; Childhood; E2A PBX1; MRD; PCR; t(1; 19)

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LEUKEMIA; CHILD; CHROMOSOME TRANSLOCATION 1; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TRANSCRIPTION; FOLLOW UP; HUMAN; HUMAN CELL; HYBRID GENE; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0030014004     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00115-8     Document Type: Article

References (8)

1. Nourse J., Mellentin J. D., Galili N., Wilkinson J., Stanbridge E., Smith S. D. & Cleary M. L. (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60, 535.
2. Hunger S. P., Galili N., Carroll A. J., Crist W. M. & Link M. L. (1991) The t(1;19)(q23;p13) results in a consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemia. Blood 77, 687.
3. Rivera G. K., Raimondi S. C., Hancock M. L., Behm F. G., Pui C. H., Abromowitch M., Minno J. J. R., Ochs J., Look A. T., Williams D. L., Murphy S. B., Dhal G. V., Kalwinsky D. K., Evans W. E., Kun L. E., Simone J. V. & Crist W. M. (1991) Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337, 61.
4. Lanza C., Gaidano G., Cimino G., Lo Coco F., Basso G., Sainati L., Pastore C., Nomdedeu J., Volpe G., Parvis G., Barisone E., Mazza U., Madon E. & Saglio, G. (1995) p53 gene inactivation in acute lymphoblastic leukemia of B-cell lineage associates with chromosomal breakpoints at 11q23 and 8q24. Leukemia 9, 955.
5. Priviter E., Kamps M. P., Hayashi Y., Inaba T., Shapiro L. H., Raimondi S. C., Behm F., Hendershot L., Carroll A. J., Baltimore D. & Look A. T. (1992) Different molecular consequences of the t(1;19) chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 79, 1781.
6. Devaraj P. E., Foroni L., Janossy G., Hoffbrand A. V. & Seeker-Walker L. M. (1995) Expression of the E2A/PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia 9, 821.
7. Guerrasio A., Martinelli G., Saglio G., Rosso C., Zaccaria A., Rosti G., Testoni N., Ambrosetti A., Izzi T., Sessarego M., Frassoni F., Gasparini P., Chiamenti A., Di Bartolomeo P. & Pignatti P. F. (1992) Minimal residual disease in transplanted chronic myelogenous leukemia patients: low incidence of PCR positive cases among 48 long disease free subjects who received unmanipulated allogeneic bone marrow transplantation. Leukemia 79, 276.
8. Chang K. S., Fan Y. K., Stass S. A., Estey E. H., Wang G. Trujillo J. M., Erickson P. & Drabkin H. (1993) Expression of AML1-ETO fusion transcript and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogens 8, 983